Injectable disease modifying agents in multiple sclerosis: pattern of medication use and clinical effectiveness
The objective of this study was to assess long-term use, adherence and efficacy of injectable disease modifying agents (DMAs). Multiple Sclerosis (MS) patients diagnosed during 2002-2010 with early treatment start and at least one year in first choice medication were included in a large university d...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2016-09-01
|
| Edice: | Neurology International |
| Témata: | |
| On-line přístup: | http://www.pagepress.org/journals/index.php/ni/article/view/6513 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|